Literature DB >> 14641276

Intravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy?

Jost B Jonas, Antje Söfker, Jochen Hayler, Robert F Degenring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14641276     DOI： 10.1046/j.1395-3907.2003.0108.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN： 1395-3907


× No keyword cloud information.
  5 in total

1.  Intravitreal triamcinolone acetonide as treatment for extensive exudative retinal detachment.

Authors:  J B Jonas
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

2.  Cell viability effects of triamcinolone acetonide and preservative vehicle formulations.

Authors:  S Shaikh; S Ho; L A Engelmann; S W Klemann
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

Review 3.  [Pharmacological approach to treatment of proliferative vitreoretinopathy].

Authors:  C S Priglinger; S Priglinger
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

Review 4.  [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

Authors:  J B Jonas; I Kreissig; B Kamppeter; R F Degenring
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

Review 5.  Managing PVR in the Era of Small Gauge Surgery.

Authors:  Manish Nagpal; Rakesh Juneja; Sham Talati
Journal:  J Ophthalmol       Date:  2021-12-04       Impact factor: 1.909
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.